Nuvation Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-75.8	-104.2	-86.85	-41.66	-33.55
Depreciation & Amortization	0.16	0.48	0.37	0.1	0.01
Share-Based Compensation	19.51	16.29	9.27	2.2	0
Other Operating Activities	-11.87	-8.69	9.02	2.83	9.11
Operating Cash Flow	-68	-96.11	-68.19	-36.53	-24.43
Capital Expenditures	-0.06	-0.36	-0.28	-0.15	-0.66
Change in Investments	8.98	63.81	-454.39	-70.18	-115.2
Investing Cash Flow	8.92	63.46	-454.67	-70.32	-115.86
Share Issuance / Repurchase	0.63	1.33	625.53	135.66	5.01
Debt Issued / Paid	0	0	0	0	14.39
Other Financing Activities	-	-	-	-2.52	124.22
Financing Cash Flow	0.63	1.33	625.53	133.14	143.62
Net Cash Flow	-58.45	-31.32	102.67	26.29	3.33
Free Cash Flow	-68.05	-96.47	-68.47	-36.67	-25.09
Free Cash Flow Per Share	-0.31	-0.45	-0.35	-0.38	-0.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).